The Wolverine Peptide
Body Protection Compound-157
BPC-157 is a pentadecapeptide (15 amino acids) derived from human gastric juice. It has demonstrated remarkable tissue-healing properties across a wide spectrum of injury types in preclinical research, including tendon, muscle, bone, ligament, and gut tissue repair. BPC-157 is one of the most extensively studied peptides in regenerative medicine, with over 100 published studies demonstrating its cytoprotective and healing properties.
BPC-157 works through multiple synergistic pathways to accelerate tissue repair and protect against damage. It promotes angiogenesis, modulates nitric oxide signaling, and upregulates growth factor expression.
Stimulates angiogenesis (new blood vessel formation) by upregulating VEGF expression, increasing blood supply to damaged tissues for faster nutrient delivery and waste removal.
Modulates the nitric oxide (NO) system, balancing vasodilation and vasoconstriction to optimize blood flow to healing tissues and reduce inflammation.
Upregulates growth hormone receptor expression in injured tissues, amplifying the body's natural regenerative signaling even without additional growth hormone.
Promotes tendon fibroblast migration and proliferation, directly accelerating the cellular processes needed for tendon and ligament repair.
Counteracts the damaging effects of NSAIDs on the gut lining and demonstrates gastroprotective properties, healing ulcers and reducing intestinal inflammation.
Research shows significantly faster repair of tendons, ligaments, muscles, and bones in preclinical models, with some studies showing healing times reduced by 50% or more.
Demonstrates powerful gastroprotective effects including healing of ulcers, reduction of inflammatory bowel symptoms, and protection against NSAID-induced gut damage.
Reduces systemic inflammation through modulation of cytokine expression and immune cell activity, without the side effects associated with traditional anti-inflammatory drugs.
Preclinical evidence suggests BPC-157 may protect neurons, support recovery from traumatic brain injury, and counteract the neurotoxic effects of certain substances.
Particularly effective for tendon-to-bone healing, with studies showing improved tensile strength and biomechanical properties in healed tissue.
Demonstrates protective effects across multiple organ systems including liver, heart, and brain, suggesting broad cytoprotective capabilities.
BPC-157 significantly accelerated healing of transected rat Achilles tendons, with improved biomechanical properties and collagen organization compared to controls.
Oral administration of BPC-157 demonstrated healing effects on inflammatory bowel disease models, reducing inflammation markers and promoting mucosal healing.
BPC-157 counteracted NSAID-induced gastrointestinal damage and showed superior gastroprotective effects compared to standard treatments in multiple models.
In traumatic brain injury models, BPC-157 reduced cerebral edema, improved neurological outcomes, and showed neuroprotective effects through multiple signaling pathways.
Systematic review of BPC-157 research identified consistent cytoprotective and wound-healing effects across 100+ preclinical studies involving various tissue types.
BPC-157 has demonstrated a very favorable safety profile in preclinical research, with no reported toxic dose (LD1 not achieved in toxicology studies). It is a naturally occurring peptide fragment derived from human gastric juice, which contributes to its tolerability. However, human clinical trial data remains limited.
Research Status
BPC-157 has over 100 published preclinical studies demonstrating tissue-healing and cytoprotective effects. While the body of animal research is extensive and consistent, large-scale human clinical trials are still in early stages. Several Phase I/II trials are underway or planned.
Regulatory Note
BPC-157 is not FDA-approved for any medical condition. It is available through licensed compounding pharmacies with a physician prescription in the United States. The FDA has expressed interest in the compound and regulatory pathways are being explored.